Wednesday, July 18, 2012

Vivus receives FDA approval for Qsymia to manage chronic weight

The U.S. Food and Drug Administration today approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management.

URL: http://www.news-medical.net/news/20120718/Vivus-receives-FDA-approval-for-Qsymia-to-manage-chronic-weight.aspx

No comments:

Post a Comment